These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults). Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A; Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111 [TBL] [Abstract][Full Text] [Related]
25. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment? Dalen JE; Alpert JS Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504 [TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience. Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873 [TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials. Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616 [TBL] [Abstract][Full Text] [Related]
28. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials. Vidale S; Russo F; Campana C; Agostoni E Angiology; 2019 Apr; 70(4):325-331. PubMed ID: 30270651 [TBL] [Abstract][Full Text] [Related]
29. Interventional closure vs. medical therapy of patent foramen ovale for secondary prevention of stroke: updated meta-analysis. Vukadinović D; Schirmer SH; Vukadinović AN; Ukena C; Scheller B; Mahfoud F; Böhm M Clin Res Cardiol; 2019 Feb; 108(2):157-166. PubMed ID: 30051178 [TBL] [Abstract][Full Text] [Related]
30. Transcatheter Patent Foramen Ovale Closure in a Child with Cryptogenic Ischemic Stroke. Lee EH; Han MY Indian J Pediatr; 2020 Aug; 87(8):653. PubMed ID: 32048224 [No Abstract] [Full Text] [Related]
31. Meta-analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke. Smer A; Salih M; Mahfood Haddad T; Guddeti R; Saadi A; Saurav A; Belbase R; Ayan M; Traina M; Alla V; Del Core M Am J Cardiol; 2018 Jun; 121(11):1393-1399. PubMed ID: 29680170 [TBL] [Abstract][Full Text] [Related]
33. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Ntaios G; Papavasileiou V; Makaritsis K; Michel P Int J Cardiol; 2013 Oct; 169(2):101-5. PubMed ID: 24041984 [TBL] [Abstract][Full Text] [Related]
34. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events. Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911 [TBL] [Abstract][Full Text] [Related]
35. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases. Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198 [TBL] [Abstract][Full Text] [Related]
36. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials. Schulze V; Lin Y; Karathanos A; Brockmeyer M; Zeus T; Polzin A; Perings S; Kelm M; Wolff G Clin Res Cardiol; 2018 Sep; 107(9):745-755. PubMed ID: 29500568 [TBL] [Abstract][Full Text] [Related]
37. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020. Gladstone DJ; Lindsay MP; Douketis J; Smith EE; Dowlatshahi D; Wein T; Bourgoin A; Cox J; Falconer JB; Graham BR; Labrie M; McDonald L; Mandzia J; Ngui D; Pageau P; Rodgerson A; Semchuk W; Tebbutt T; Tuchak C; van Gaal S; Villaluna K; Foley N; Coutts S; Mountain A; Gubitz G; Udell JA; McGuff R; Heran MKS; Lavoie P; Poppe AY; Can J Neurol Sci; 2022 May; 49(3):315-337. PubMed ID: 34140063 [TBL] [Abstract][Full Text] [Related]
38. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929 [TBL] [Abstract][Full Text] [Related]
39. Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience. Ford MA; Reeder GS; Lennon RJ; Brown RD; Petty GW; Cabalka AK; Cetta F; Hagler DJ JACC Cardiovasc Interv; 2009 May; 2(5):404-11. PubMed ID: 19463462 [TBL] [Abstract][Full Text] [Related]
40. Patent foramen ovale closure for patients with cryptogenic stroke: A systematic review and comprehensive meta-analysis of 5 randomized controlled trials and 14 observational studies. Chen X; Chen SD; Dong Y; Dong Q CNS Neurosci Ther; 2018 Oct; 24(10):853-862. PubMed ID: 29804325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]